1. Meet Dr. Jingqi Huang
Updated July 2021
If there’s one thing you should know about Dr. Jingqi Huang, it’s that she’s all about teamwork.
Throughout her professional career, which began as a doctor to her current position as Senior Vice President of
in vivo Pharmacology, she recognizes that teamwork is essential, and she thrives on keeping her team challenged and motivated.
As one of the first members of Pharmaron’s
in vivo pharmacology team, she eagerly accepted the challenges with growing a new department. Now eight years later, Jingqi is proud of the team and the department she has grown.
By instilling trust, being honest and respectful and recognizing those who make contributions, she has created a team that is confident, innovative and eager to take on new partner projects. Establishing focused specialty areas within her team has been a key factor to building confidence. This approach allows team members to answer detailed questions easily, as well as present their new knowledge to their peers in team meetings. As a result, Jingqi finds the team meetings to be full of energy and excitement.
Jingqi’s
in vivo pharmacology team works closely with Pharmaron’s
in vitro biology and PK teams. Such collaboration typically starts from discussion of a particular study with a partner, followed by study plan formulation, execution, discussion of results, data interpretation and conclusion.
As a result of her team’s efforts, models across different therapeutic areas have been established and validated. These models include oncology (PDX, CDX, imaging, resistant, immuno-oncology), CNS, inflammation and pain, in addition to hemostasis, leukocytopenia, intestine mobility, anemia, wounding/healing and renal failure. The team is proud to support our major pharma and biotech partners by testing the efficacy and assessing TE/PD biomarkers in diseased animal models for small and large molecules in the drug discovery process.
To emphasize the importance of teamwork, Jingqi plans team building events throughout the year. Events range from pot-luck lunches to more elaborate adventures, such as rafting and Jeep rides through the mountains.
“As my team grows, team building becomes even more important. It’s a chance for us to have fun and get to know each other better outside of the lab. The energy and enthusiasm each event brings back to the office makes me look forward to the next one.”
About Dr. Jingqi Huang
Jingqi Huang is Vice President of
in vivo Pharmacology and joined Pharmaron in 2009. Prior to this, she worked as a research pharmacologist at the Merck Frosst Centre for Therapeutic Research in Montreal, Canada and Human Genetic Laboratories, Research Institute of McGill University Teaching Hospital (Montreal Children’s Hospital).
In addition, she has 3 years of clinical practice background. She received her M.D. from Tianjin Medical University in China and a M.Sc. in Pathology from McGill University in Canada. She also completed the full term doctoral training at McGill Cancer Center. She has co-authored several scientific articles in peer-reviewed journals, including four cover page articles. In her spare time, she enjoys hiking, spending time outside and planning her team’s next adventure.
For more information about Pharmaron's
in vivo pharmacology services,
click here.
4. Forum on Innovation for Life Sciences
In honor of the Ningbo-Hangzhou Bay campus opening and our commitment to science and technology, a forum was held the day of the Ningbo site ceremony.
Nine speakers from academia and industry presented on topics covering novel and effective synthetic methodologies including chiral and non-chiral catalysis and fluorine chemistry, highly efficient total synthesis of complex natural products, automation of synthesis and its integration with bioassays, the discovery of new generation of drugs against cancer, autoimmune diseases and anemia and the importance of crystallization in late development.
These talks are representative of the current state-of-the-art of synthetic organic chemistry, crystallization technology, and drug discovery and development in the global academia and industry. The speakers also discussed the industry’s strategic thinking on how to transform fundamentally drug discovery and development performance, with case studies.
Speakers:
- Prof. Qilin Zhou, Nankai University
- Dr. Robert Geertman, Janssen Research and Development
- Dr. Michael Kress, Merck Sharp & Dohme
- Dr. Michael Varney, Genentech
- Dr. Stevan Djuric, AbbVie
- Dr. Sergii Pazenok, Bayer AG
- Dr. Helmut Haning, Bayer AG
- Dr. Peter Toogood, Lycera
- Prof. Darren Dixon, University of Oxford